Suven Life Sciences (SUVEN.NSE)

Suven Life Sciences share price today, ATLAS forecast and fair value

Healthcare · Drug Manufacturers - Specialty & Generic · National Stock Exchange of India · India

₹261.40▼ -0.23%

Prices as of Oct 27, 2026 · INR

ATLAS fair value

ATLAS has no fair value for this stock today.

Chance of rising in 1 month

48%

that it ends higher than today in 21 sessions

0%coin flip 50%100%

This is just the summary. See everything on Suven Life Sciences in ATLAS

ATLAS's own quantitative analysis, all in one place.

Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
Officers and shareholdersWho runs the company and which funds hold its shares.
Customer and supplier mapWho it does business with, from its own filings.
ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
AlertsWe let you know when something changes in your stocks.

See everything included

Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
NewsThe latest on the company, in one place.
Crisis simulatorHow your portfolio would do in a crash like 2008.
Practice risk-free$10,000 in virtual money to invest at real prices.
Global screenerSearch US stocks and stocks from 47 countries with filters.

On Suven Life Sciences

Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
Officers and shareholdersWho runs the company and which funds hold its shares.
Customer and supplier mapWho it does business with, from its own filings.
Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
NewsThe latest on the company, in one place.

And for you

ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
AlertsWe let you know when something changes in your stocks.
Crisis simulatorHow your portfolio would do in a crash like 2008.
Practice risk-free$10,000 in virtual money to invest at real prices.
Global screenerSearch US stocks and stocks from 47 countries with filters.

Get started →

Plans from €3.99 a month.

ATLAS's model gives Suven Life Sciences a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.

In half of the simulated outcomes the price ends between ₹237.72 and ₹284.34; in 9 out of 10, between ₹202.83 and ₹333.25. Estimated annual volatility is 50%.

Price, last 12 months (weekly close)

Key numbers

Market cap: ₹82.0B
Market cap (USD): $866M
Dividend yield: 2.10%
52-week high: ₹403.35
52-week low: ₹124.11
Revenue (12 months): ₹88.1M
Net margin: 86.1%
Beta: 0.89

What this means

ATLAS does not publish a fair value for SUVEN.NSE right now, but it does show its odds of rising: close to a coin flip.

Over the last 52 weeks SUVEN.NSE has traded between ₹124.11 and ₹403.35. Today it is 35.2% below that high and 111% above its low.

Its beta is 0.89: it moves roughly in line with the market.

About the company

Suven Life Sciences Ltd. is a biopharmaceutical company that focuses on discovering, developing, and commercializing new chemical entities (NCEs) for the treatment of severe central nervous system (CNS) disorders.

Want to see everything about Suven Life Sciences?

Get started →

Plans from €3.99 a month.

Comparable companies

Other companies in the same line of business:

Frequently asked questions

What does Suven Life Sciences do?

What is the chance SUVEN.NSE goes up next month?

48%: close to a coin flip. In half of the simulated outcomes, SUVEN.NSE ends the month between ₹237.72 and ₹284.34.

How big is Suven Life Sciences and what is its P/E ratio?

Suven Life Sciences's market capitalization is ₹82.0B. We do not show a P/E because it has no positive earnings to base one on.

Does Suven Life Sciences pay a dividend?

Yes. SUVEN.NSE's current dividend yield is 2.10% at today's price (₹261.40).

Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer